JP2024511353A5 - - Google Patents
Info
- Publication number
- JP2024511353A5 JP2024511353A5 JP2023556936A JP2023556936A JP2024511353A5 JP 2024511353 A5 JP2024511353 A5 JP 2024511353A5 JP 2023556936 A JP2023556936 A JP 2023556936A JP 2023556936 A JP2023556936 A JP 2023556936A JP 2024511353 A5 JP2024511353 A5 JP 2024511353A5
- Authority
- JP
- Japan
- Prior art keywords
- risperidone
- long
- acting
- preparation
- injectable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163162272P | 2021-03-17 | 2021-03-17 | |
| US63/162,272 | 2021-03-17 | ||
| IB2021052248 | 2021-03-17 | ||
| IBPCT/IB2021/052248 | 2021-03-17 | ||
| US202163208860P | 2021-06-09 | 2021-06-09 | |
| US63/208,860 | 2021-06-09 | ||
| US202163270174P | 2021-10-21 | 2021-10-21 | |
| US63/270,174 | 2021-10-21 | ||
| PCT/EP2022/057009 WO2022195018A1 (en) | 2021-03-17 | 2022-03-17 | Long acting injectable formulation comprising risperidone and biodegradable polymers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511353A JP2024511353A (ja) | 2024-03-13 |
| JP2024511353A5 true JP2024511353A5 (enExample) | 2025-04-02 |
Family
ID=81307068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023556936A Pending JP2024511353A (ja) | 2021-03-17 | 2022-03-17 | リスペリドン及び生分解性ポリマーを含む長時間作用型注射用製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20240148641A1 (enExample) |
| EP (1) | EP4308077A1 (enExample) |
| JP (1) | JP2024511353A (enExample) |
| KR (1) | KR20230158088A (enExample) |
| AU (1) | AU2022236485A1 (enExample) |
| BR (1) | BR112023018652A2 (enExample) |
| CA (1) | CA3208006A1 (enExample) |
| IL (1) | IL304980A (enExample) |
| MX (1) | MX2023010925A (enExample) |
| WO (1) | WO2022195018A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2026501805A (ja) * | 2023-01-10 | 2026-01-16 | メドインセルル エス．エー． | オランザピン組成物及び使用の方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112012010195A2 (pt) * | 2009-10-30 | 2016-04-26 | Janssen Pharmaceutica Nv | regime de dosagem associado a ésteres de paliperidona injetável de longa ação |
| US10463607B2 (en) * | 2010-05-31 | 2019-11-05 | Laboratorios Farmaceutics Rofi S.A. | Antipsychotic Injectable Depot Composition |
| KR101424163B1 (ko) * | 2010-12-24 | 2014-08-01 | 주식회사 삼양바이오팜 | 수난용성 약물 함유 서방성 마이크로입자 및 그 제조방법 |
| US9023897B2 (en) * | 2010-12-29 | 2015-05-05 | Medincell | Biodegradable drug delivery compositions |
| EP2866837B1 (en) | 2012-06-27 | 2022-12-14 | Medincell S.A. | Biodegradable drug delivery for hydrophobic compositions |
| US20190015415A1 (en) * | 2015-09-30 | 2019-01-17 | Indivior Uk Limited | Methods for treating schizophrenia |
| CN107213136B (zh) * | 2017-06-07 | 2021-06-01 | 广州帝奇医药技术有限公司 | 一种长效缓释药物制剂及其制备方法 |
| WO2020154315A1 (en) * | 2019-01-22 | 2020-07-30 | Indivior Uk Limited | Methods for treating schizophrenia |
| MX2022003051A (es) * | 2019-09-13 | 2022-06-14 | Medincell S A | Formulaciones para la administracion de farmacos. |
-
2022
- 2022-03-17 JP JP2023556936A patent/JP2024511353A/ja active Pending
- 2022-03-17 IL IL304980A patent/IL304980A/en unknown
- 2022-03-17 KR KR1020237035519A patent/KR20230158088A/ko active Pending
- 2022-03-17 CA CA3208006A patent/CA3208006A1/en active Pending
- 2022-03-17 US US18/281,392 patent/US20240148641A1/en active Pending
- 2022-03-17 WO PCT/EP2022/057009 patent/WO2022195018A1/en not_active Ceased
- 2022-03-17 BR BR112023018652A patent/BR112023018652A2/pt unknown
- 2022-03-17 MX MX2023010925A patent/MX2023010925A/es unknown
- 2022-03-17 AU AU2022236485A patent/AU2022236485A1/en active Pending
- 2022-03-17 EP EP22716046.2A patent/EP4308077A1/en active Pending
-
2024
- 2024-02-23 US US18/585,349 patent/US12329851B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU764626B2 (en) | Pharmaceutical formulations of taxanes | |
| WO2015033302A2 (en) | Fulvestrant compositions | |
| US20230225962A1 (en) | Methods of administering an aripiprazole injectable preparation | |
| EP3982967A1 (en) | Methods for treating pulmonary arterial hypertension | |
| CN103370066A (zh) | 用于治疗癌症的包含威罗菲尼和干扰素的组合疗法 | |
| JP2022535694A5 (enExample) | ||
| JP2024511353A5 (enExample) | ||
| JP2022548616A5 (enExample) | ||
| US3228834A (en) | Pharmaceutical diluent compositions | |
| US20250268816A1 (en) | Extended-release formulation containing cresol | |
| FI4027973T3 (fi) | Lääkkeensaattoformulaatioita | |
| CN105726472B (zh) | 苯达莫司汀药剂组合物及应用 | |
| KR20100051694A (ko) | 주사제, 주사 용액, 및 주사 키트 제제 | |
| JP2024501166A (ja) | フルベストラントの徐放性医薬組成物及びその製造方法 | |
| US10398785B2 (en) | Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use | |
| IL319451A (en) | HIV treatment with CABOTEGRAVIR and RILPIVIRINE in pediatric patients | |
| WO2014015153A2 (en) | Compositions and methods for treating ewing's sarcoma and other disorders related to ews-fli1 | |
| EP4164608A1 (en) | Pharmaceutical compositions | |
| JP2018530597A (ja) | フルベストラント組成物 | |
| JP2024545690A (ja) | 溶解度が改善されたフルベストラントの医薬組成物及びその製造方法 | |
| US20040072797A1 (en) | Storage stable eplerenone formulation | |
| JP2778632B2 (ja) | 卵巣癌の治療用医薬組成物 | |
| US20240207217A1 (en) | Improved treatment methods for cabazitaxel | |
| RU2002106874A (ru) | Фармацевтические композиции для лечения псориаза | |
| US20150174097A1 (en) | Treating ewing's sarcoma and ews-fli1 related disorders |